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Country trends

What’s leading the curve: research or policy?
SARAH COUFFIGNAL-SZYMCZAK

Stem cells are characterized by the ability to renew
themselves and differentiate into a diverse range of
specialized cell types. Therefore, stem cell research opens
the possibility of new technologies with great therapeutic
potential for many medical conditions. The two main types
of mammalian stem cells are adult stem cells, which are
found in adult tissues, and embryonic stem cells, which
are isolated from the inner cell mass of early embryos.
The latter are at the center of a moral and ethical debate
on research involving the creation, use and destruction of
human embryonic stem cells.
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ents’ agreement that the superfluous embryos can be used for
research purposes. Taking into account the fact that research
manuscripts can take up to a year to appear in a journal, this
relaxing of the law may be reflected in a slight increase in the
number of articles on this subject published by French authors
in 2005. The law is due to be re-examined at the end of the year,
so the future of stem cell research in France is still uncertain.

UK: ranked 4

The UK has a well-established system for regulating the creation and use of embryos: the Human Fertilisation and Embryology Act (HFEA) of 1990. This act allows the creation and use of
embryos for research, provided that the research is for one of
five specified purposes and has been granted a license by the
HFEA. The UK Stem Cell Initiative, launched in March 2005,
aims at defining a 10-year vision for UK stem cell research
and coordinating its public and private funding. This initiative
matches a modest increase in the number of articles published
by UK authors in the following years.

Germany: ranked 3
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Stem cell research in the USA, Japan, Germany, the UK and
France may be affected by national policy.
Stem cell research is an exciting but controversial field and has
been the subject of intense debate in recent years. Despite the
controversy, the field has sustained a strong growth over the
past decade (~11%). National policies on stem cell research
have been evolving with the debate and influencing research
outputs, as can be seen in the following overview of the most
prolific countries during the past decade.

France: ranked 5

Since the 1994 bioethics laws, embryo research has in principle
been forbidden in France. However, these laws are evaluated
every five years and the bioethic law of August 6, 2004, allowed
research with a therapeutic aim and under extremely controlled conditions to be carried out. Research is only permitted on
embryos created as a by-product of IVF and only with the par-

Any creation of human stem cells that also involves the use of
embryos is prohibited in Germany by the Embryo Protection
Law of January 1, 1991. However, this law does not cover the
importation of stem cell lines produced in other countries from
human embryos and their use in Germany for the purposes of
research. In response, the Bundestag adopted the Stem Cell
Law on July 1, 2002. In principle, this law prohibits the importation and use of human embryonic stem cells except for research
under exceptional conditions. Germany’s peak in output in 2001
could be interpreted as an advanced reaction to the impending
2002 Stem Cell Law. In May 2007, the Stem Cell Law was discussed by the German Parliament, the Bundestag’s, Committee
on Education, Research and Appraisal of the Consequences of
Technology, a fact that could suggest a need for reform.

Japan: ranked 2

Since June 6, 2001, the law on Human Cloning Techniques and
Other Similar Techniques has been enforced in Japan. This law
specifically bans reproductive cloning and recommends the
elaboration of national guidelines for the creation of “Specified Embryos” for research purposes. On July 23, 2004, Japan’s
Council for Science and Technology Policy, the Japanese government’s highest science and technology policy body, approved
the final report of its Bioethics Expert Panel on human embryo
and stem cell research. The report recommended allowing the
creation of human embryos for stem cell research. Japan’s
relatively steady increase in output could reflect the absence of
any drastic new legislation in recent years.
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USA: ranked 1

On August 9, 2001, President George Bush allowed the funding
of stem cell research through taxpayer financing, but only with
strict limits. The USA’s peak in output in 2001 could correspond
to an accelerated publication of publicly funded research at the
time of President Bush’s restrictive statement; surprisingly,
commentary on the legislation is scarce in the scientific
literature of the time. The House of Representatives passed a
bill on May 24, 2005, to expand federal financing for embryonic
stem cell research, defying a veto threat from then President
Bush. On March 9, 2009, President Barack Obama issued
Executive Order 13505, Removing Barriers to Responsible
Scientific Research Involving Human Stem Cells, revoking
President Bush’s statement of August 9, 2001, as well as its
supplemental executive order of June 20, 2007, and opens the
door to new horizons for the future of stem cell research in the
US. The continued upswing in research outputs on stem cells
may reflect the fact that many researchers have sought nonfederal funding for their research or diversified their research
efforts into permissible techniques for acquiring human stem
cells. Recently, two leading bioethicists have even argued
that Bush’s restrictive policy may have inadvertently pushed
stem cell research, and thinking about the underlying ethical
dilemmas, much further forward. (1)

Open future

As the debate on stem cell research evolves, national policies
follow: advances in the field raise new ethical issues, entailing
an evolution of the controversy, and a resulting need for new
regulations. The ethics of stem cell research are still controversial and, despite a recent tendency towards an increase in
legislative permissiveness, the future of this exciting field of
research is still to be written.
Reference:
(1) ‘Benefits of the stem cell ban’, New Scientist, available at: www.the-scientist.com/news/display/55752
(registration, which is free, is required to read this article)
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